| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |